The Department of Justice is warning drug companies that the DOJ is investigating them for corruption. The DOJ will be primarily focusing on foreign dealings.
The U.S. Justice Department plans to focus on prosecuting those in the pharmaceutical industry who try to bribe foreign officials for preferential treatment of their products, a senior official said on Thursday.The department has been examining fraud and corruption in the healthcare system as part of the overall Obama administration drive to overhaul the system and reduce skyrocketing costs.
